Anti-viral remdevisir gets EU endorsement as first Covid-19 drug

  • 📰 trtworld
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Gilead's antiviral, remdesivir, gets endorsement as first Covid-19 treatment drug in Europe

A lab technician holds the coronavirus disease drug remdesivir at Eva Pharma Facility in Cairo, Egypt, June 25, 2020.

The European Medicines Agency said on Thursday its human medicines committee recommended the drug's use in adults and adolescents from 12 years of age with pneumonia who require oxygen support. The research, published in leading journal, the New England Journal of Medicine, in May, showed that injections of remdesivir sped up patient recovery compared with a placebo.The price of the drug in the region is not yet known. In the United States, it could be priced up to $5,080 per course, while Indian generic drugmakers will sell the treatment between 5,000 rupees to 6,000 rupees .

The EU's conditional marketing authorisation allows treatment to be sold for a year in the 27-nation trading bloc before all necessary data on its efficacy and side-effects are available. Gilead has to submit final data by December.Demand for the drug soared after it became a front-runner following promising trials.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

juneymb is this the same drug that is used for swine flu because I saw folks using it the first day they fell sick.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in HEALTH

Health Health Latest News, Health Health Headlines